Your browser doesn't support javascript.
loading
IL6 is associated with response to dasatinib and cetuximab: Phase II clinical trial with mechanistic correlatives in cetuximab-resistant head and neck cancer.
Stabile, L P; Egloff, A M; Gibson, M K; Gooding, W E; Ohr, J; Zhou, P; Rothenberger, N J; Wang, L; Geiger, J L; Flaherty, J T; Grandis, J R; Bauman, J E.
Affiliation
  • Stabile LP; Departments of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, United States.
  • Egloff AM; Departments of Otolaryngology and Molecular & Cell Biology, Boston University, Boston, United States.
  • Gibson MK; Department of Medicine, Case Western Reserve University, Cleveland, United States.
  • Gooding WE; Departments of Biostatistics, University of Pittsburgh, Pittsburgh, United States.
  • Ohr J; Departments of Medicine, University of Pittsburgh, Pittsburgh, United States.
  • Zhou P; Departments of Otolaryngology, Pittsburgh, United States.
  • Rothenberger NJ; Departments of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, United States.
  • Wang L; Departments of Otolaryngology, Pittsburgh, United States.
  • Geiger JL; Departments of Medicine, University of Pittsburgh, Pittsburgh, United States.
  • Flaherty JT; Departments of Medicine, University of Pittsburgh, Pittsburgh, United States.
  • Grandis JR; Department of Otolaryngology-Head and Neck Surgery, University of California San Francisco, San Francisco, United States.
  • Bauman JE; Departments of Medicine, University of Pittsburgh, Pittsburgh, United States. Electronic address: jebauman@email.arizona.edu.
Oral Oncol ; 69: 38-45, 2017 06.
Article in En | MEDLINE | ID: mdl-28559019
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Antineoplastic Combined Chemotherapy Protocols / Interleukin-6 / Dasatinib / Cetuximab / Head and Neck Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Oral Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Carcinoma, Squamous Cell / Antineoplastic Combined Chemotherapy Protocols / Interleukin-6 / Dasatinib / Cetuximab / Head and Neck Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Oral Oncol Journal subject: NEOPLASIAS Year: 2017 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido